Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00185718 · ClinicalTrials.gov registry record
Impact of Treatment Induced Premature Menopause on Quality of Life
A clinical trial, sponsored by Stanford University.
- Completed
- Registry status
- 97
- Enrollment target
NCT00185718: Completed study, sponsored by Stanford University.
NCT00185718 is a clinical trial that has completed, run by Stanford University. The registered enrollment target is 97 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00185718 has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- 97 participants
- Enrollment target
Study Summary
To understand the impact of treatment induced menopause on quality of life and sexuality following blood and marrow transplantation.
Primary Outcome
To describe the impact of premature menopause on sexuality and quality of life.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 97 participants |
| Start Date | 2003-11 |
| Est. Completion | 2010-09 |
What the finished NCT00185718 record still lists
NCT00185718 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 97 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT00185718 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00185718 about?
NCT00185718 is a clinical study titled "Impact of Treatment Induced Premature Menopause on Quality of Life". To understand the impact of treatment induced menopause on quality of life and sexuality following blood and marrow transplantation.
What is the current status of trial NCT00185718?
This trial is currently completed. The enrollment target is 97 participants. The study started on 2003-11. Estimated completion is 2010-09.
Who is sponsoring clinical trial NCT00185718?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03948490 · 97 participants · NA
Rehabilitation and Longitudinal Follow-up of Cognition in Adult Lower Grade Gliomas
- NCT04140487 · 97 participants · Phase 1
Azacitidine, Venetoclax, and Gilteritinib in Treating Patients With Recurrent/Refractory FLT3-Mutated Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia, or High-Risk Myelodysplastic Syndrome/Myeloproliferative Neoplasm
- NCT04196413 · 97 participants · Phase 1
GD2 CAR T Cells in Diffuse Intrinsic Pontine Gliomas (DIPG) & Spinal Diffuse Midline Glioma(DMG)
- NCT05223816 · 97 participants · Phase 2
An Open-Label, Multiple-Center, Phase IIa/IIb Clinical Trial to Evaluate the Efficacy, Safety and Tolerability of VG161 as Monotherapy and in Combination With Nivolumab for Treatment of Patients With Hepatocellular Carcinoma or Intrahepatic Cholangiocarcinoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia